Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps

Emerging evidence suggests that soluble epoxide hydrolase (sEH) inhibition is a valuable therapeutic strategy for the treatment of numerous diseases, including those of the liver. sEH rapidly degrades cytochrome P450-produced epoxygenated lipids (epoxy-fatty acids), which are synthesized from omega-...

Descripción completa

Detalles Bibliográficos
Autores principales: Warner, Jeffrey, Hardesty, Josiah, Zirnheld, Kara, McClain, Craig, Warner, Dennis, Kirpich, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345757/
https://www.ncbi.nlm.nih.gov/pubmed/32545637
http://dx.doi.org/10.3390/biology9060124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345757/
https://www.ncbi.nlm.nih.gov/pubmed/32545637
http://dx.doi.org/10.3390/biology9060124

Ejemplares similares